Radiation recall during cemiplimab therapy for locally advanced cutaneous squamous cell carcinoma

Dermatol Ther. 2020 Nov;33(6):e14417. doi: 10.1111/dth.14417. Epub 2020 Oct 23.

Authors

Mario Vaccaro¹, Lucrezia Bertino¹, Mariacarmela Santarpia², Giuseppe Altavilla², Serafinella P Cannavò¹

Affiliations

¹ Department of Clinical and Experimental Medicine-Dermatology, University of Messina, Messina, Italy.
² Department of Human Pathology "G. Barresi", Medical Oncology Unit, University of Messina, Messina, Italy.

PMID: 33068047
DOI: 10.1111/dth.14417

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Antineoplastic Agents, Immunological* / therapeutic use
Carcinoma, Squamous Cell* / drug therapy
Carcinoma, Squamous Cell* / radiotherapy
Humans
Skin Neoplasms* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
cemiplimab